Joseph Dybowski
Vice President - Nonclinical Safety at Alnylam Pharmaceuticals
- Role
- Vice President - Toxicology at Alnylam Pharmaceuticals
- Location
- Cambridge, MA, US
- LinkedIn followers
- 500 followers
ScienceView LinkedIn profile
About Joseph Dybowski
Experienced Drug Developer Leading Global Nonclinical Safety Assessment of RNAi TherapeuticsSpecialties: DABT, C (ASCP), Memberships: Society of Toxicology, American Chemical Society
Experience
Vice President - Toxicology
Jul 2019 — Present · Cambridge, MA, US
Education
University of Michigan
PhD, Toxicology
1992 — 1999
University of Michigan
MPH, Toxicology
1990 — 1992
University of Michigan
BS, Biology
1988 — 1990
Skills
- Inflammation
- Biotechnology
- Pharmaceuticals
- Ind
- Pharmacology
- Drug Discovery
- Toxicology
- CRO
- Laboratory
- Drug Development
- Biopharmaceuticals
- Pharmaceutical Industry
- Sop
- Fda
- Risk Assessment
- Pharmacokinetics
- Adme
- Regulatory Submissions
- In Vivo
- Glp
- Analytical Chemistry
- Lc-Ms
- Life Sciences
- Immunology
- Lifesciences
- Chemistry
- Clinical Research
- In Vitro
- Biomarkers
- Clinical Development
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.